跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
OXYCONTIN 20mg prolonged release tablets - HSA Drug Approval Details
Approvals
/
HSA
/
OXYCONTIN 20mg prolonged release tablets
Approved
STANDARD
OXYCONTIN 20mg prolonged release tablets
Unknown
🇸🇬 Health Sciences Authority
Approval Date
Jan 13, 2026
Approval ID
f2e640c9fe9ef1ae
Company
Unknown
Type
Standard
Approval Details
Approval Id
f2e640c9fe9ef1ae
Drug Name
OXYCONTIN 20mg prolonged release tablets
Active Ingredients
Oxycodone hydrochloride
20mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jan 13, 2026
Approval ID
f2e640c9fe9ef1ae
Type
Standard
Back to HSA Approvals